hby-097 and Viremia

hby-097 has been researched along with Viremia* in 1 studies

Trials

1 trial(s) available for hby-097 and Viremia

Article	Year
Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load. Lancet (London, England), 1997, May-24, Volume: 349, Issue:9064 Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiviral Agents; Cohort Studies; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Mutation; Placebos; Quinoxalines; Reverse Transcriptase Inhibitors; Viral Load; Viremia; Virus Replication	1997

Article

Year

Second-generation non-nucleosidic reverse transcriptase inhibitor HBY097 and HIV-1 viral load.

Lancet (London, England), 1997, May-24, Volume: 349, Issue:9064

Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Antiviral Agents; Cohort Studies; Double-Blind Method; Drug Combinations; Drug Resistance, Microbial; HIV Infections; HIV-1; Humans; Mutation; Placebos; Quinoxalines; Reverse Transcriptase Inhibitors; Viral Load; Viremia; Virus Replication

1997